6-K ·Filed Sep 2, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the reconvened meeting on September 3 for any material shareholder votes or corporate actions; this filing itself is a non-event.
Latest settled — T+5d ⚠ clustered
GLMD ▲ +18.11% at T+5d
NEUTRAL call +18.11% · α vs SPY +19.26% · entry $3.92 → $4.63
T+1d
-1.02%
call -1.02% · α -0.64%
$3.88
settled 8w ago
T+5d
+18.11%
call +18.11% · α +19.26%
$4.63
settled 7w ago
T+20d
Pending
due 26d ago
T+60d
Pending
in 4w
Price Chart
Loading chart...
Executive Summary
Galmed Pharmaceuticals filed a 6-K reporting that its Annual General Meeting of Shareholders, convened on September 2, 2026, was adjourned for one day to September 3, 2026 due to lack of quorum. This is a routine procedural matter with no material financial or operational impact on the company.
Key Facts
- Annual General Meeting convened on September 2, 2026 was adjourned for one day due to lack of quorum.
- Meeting will reconvene on September 3, 2026 at 4:00 p.m. Israel time at the same location.
Financial Impact
No financial impact from a procedural adjournment.
Risk Factors
- Lack of quorum may indicate low shareholder engagement, but no immediate operational risk.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-041231 |
| Document: 0001493152-26-041231-index-headers.html | 0001493152-26-041231 |
| Document: 0001493152-26-041231-index.html | 0001493152-26-041231 |
| Document: 0001493152-26-041231.txt | 0001493152-26-041231 |
15 reports for GLMD
57% Hit rate @ T+5 Went positive at some point 6 of 8 best @ T+5▲ +31.26%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 6-K | $4.63 $3.63 | ▼ −21.71% | ▼ −21.37% | — |
Sep 4, 2026 7w ago | EFFECT | $3.88 $4.63 | ▼ −19.33% | ▼ −20.54% | — |
Sep 3, 2026 7w ago | 6-K | $3.88 $4.63 | ▲ +19.33% | ▲ +20.54% | — |
Sep 2, 2026 7w ago | 6-K | $3.92 $4.63 | ▲ +18.11% | ▲ +19.26% | — |
Aug 19, 2026 9w ago | 6-K | $4.77 $4.33 | ▼ −9.22% | ▼ −8.84% | — |
Aug 17, 2026 10w ago | 6-K | $0.5134 | awaiting T+5 | — | — |
Jul 28, 2026 13w ago | 6-K | $0.5340 $0.5754 | ▲ +7.75% | ▲ +3.64% | — |
Jul 16, 2026 14w ago | 6-K | $0.5501 $0.5530 | ▲ +0.53% | ▲ +2.20% | — |
Jun 22, 2026 18w ago | 6-K | $0.5641 $0.5709 | ▲ +1.21% | ▲ +1.66% | — |
Jun 8, 2026 20w ago | 6-K | $0.4693 $0.6160 | ▲ +31.26% | ▲ +29.15% | — |
Showing 10 of 15
US Market Status
Market Open — Closes in 3h 24m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers